Showing stories 1 - 10 of about 120
This Metric Says You Are Smart to Buy Sanofi SA (ADR) (SNY)
To most investors, hedge funds are seen as slow, outdated financial vehicles of the past. While there are more than 8000 funds in operation at the moment, we look at the leaders of this group, around 450 funds.
Why The Pfizer Inc. (PFE)-Teva Pharmaceutical Industries Ltd (ADR) (TEVA ...
In 2006, Apotex made an at-risk launch of its generic version of Plavix -- sold by Sanofi SA (ADR) (NYSE:SNY) and Bristol-Myers Squibb Co.
Bristol Myers Squibb Co (BMY), Momenta Pharmaceuticals, Inc. (MNTA): White ...
And the list goes on Last year, the SEC charged a bunch of high school friends who worked at Celgene Corporation (NASDAQ:CELG), Sanofi SA (ADR) (NYSE:SNY), and Stryker Corporation (NYSE:SYK) who reportedly shared non-public information about ...
5 Costliest Microbes in Financial History
In 2009, biotechnology trailblazer Genzyme, now a part of Sanofi (NYSE: SNY ) , demonstrated the worst-case scenario facing investors of today's biotechnology and industrial biotech companies: contamination.
Related articles »
Morning News: Apple, Google, McDonald's, Berkshire, AstraZeneca, IHS
French drug maker Sanofi SA (ADR) (NYSE:SNY) said its Sanofi Pasteur vaccines division has secured clearance from the U.S.
Biotechs Lose Ground As Achillion Pharmaceuticals, Inc. (ACHN) Takes a Dive
Like Biogen, however, Regeneron Pharmaceuticals Inc (NASDAQ:REGN)'s a company with a drug preparing for a strong future. The company's asthma therapy dupilumab, made jointly with Big Pharma's Sanofi SA (ADR) (NYSE:SNY), absolutely crushed a ...
ImmunoGen, Inc. (IMGN), Seattle Genetics, Inc. (SGEN), Celldex Therapeutics ...
... Inc. (NASDAQ:IMGN) has partnerships with Roche, Bayer, Sanofi SA (ADR) (NYSE:SNY), Biotest, Amgen, Inc. (NASDAQ:AMGN), and most recently Novartis AG (ADR) (NYSE:NVS), each yielding milestone payments and royalties upon commercialization.
Sanofi SA (SNY): FDA Licenses New Four-Strain Influenza Vaccine
(By Balachander) Sanofi SA (NYSE: SNY) said the U.S. Food and Drug Administration (FDA) has approved the supplemental biologics license application (sBLA) for licensure of its four-strain influenza vaccine, Fluzone Quadrivalent vaccine, for broad age ...
Related articles »
Regeneron Pharmaceuticals Inc. (REGN), GlaxoSmithKline plc (GSK): The First ...
Sanofi SA (ADR) (NYSE:SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) are developing dupilumab to cure moderate to severe allergic asthma.
Related articles »
Hedge Funds Are Dumping Merck & Co., Inc. (MRK)
These stocks are Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE), Novartis AG (ADR) (NYSE:NVS), GlaxoSmithKline plc (ADR) (NYSE:GSK), and Sanofi SA (ADR) (NYSE:SNY). This group of stocks are in the drug manufacturers - major industry and ...
Related articles »